Schoedon G, Troppmair J, Fontana A, Huber C, Curtius H C, Niederwieser A
Eur J Biochem. 1987 Jul 15;166(2):303-10. doi: 10.1111/j.1432-1033.1987.tb13515.x.
The cellular origin and the control of neopterin release associated with immune stimulation was studied in cell cultures. Using purified human mononuclear cells, the intracellular change in concentrations of GTP and pterins was measured under various kinds of stimulation. Three enzymes involved in tetrahydrobiopterin biosynthesis, i.e. GTP cyclohydrolase I, 6-pyruvoyl tetrahydropterin synthase and sepiapterin reductase, were also determined. Human macrophages stimulated with culture supernatant from activated T-lymphocytes were the main producers of neopterin. In these cells, GTP cyclohydrolase I activity was elevated due to high GTP levels and therefore neopterin accumulated. Human macrophages lack 6-pyruvoyl tetrahydropterin synthase activity. Exogenous tetrahydrobiopterin added to the culture medium of stimulated T cells and macrophages suppressed the elevation of GTP cyclohydrolase I activity and neopterin concentration, but not the elevation of intracellular GTP. Stimulation of macrophages with recombinant human interferon-gamma and neutralization of the effect of T cell supernatants by addition of a monoclonal antibody specific for human interferon-gamma showed that immune interferon induced the alterations in GTP cyclohydrolase I activity and neopterin concentration. In the human macrophage line U-937 and in the leukemia line HL-60, no GTP cyclohydrolase I activity or intracellular pterins were detected, but high levels of GTP. In mouse mononuclear cells, no neopterin was detected, but biopterin and pterin. After stimulation, biopterin was elevated in the same way as neopterin in human mononuclear cells. This is explained by the different regulation of the rate-limiting steps of tetrahydrobiopterin biosynthesis in man and in mouse. These results suggest that neopterin is an unspecific marker for the activation of the cellular immune system.
在细胞培养中研究了与免疫刺激相关的新蝶呤释放的细胞起源及其控制。使用纯化的人单核细胞,在各种刺激下测量了GTP和蝶呤浓度的细胞内变化。还测定了参与四氢生物蝶呤生物合成的三种酶,即GTP环化水解酶I、6-丙酮酰四氢蝶呤合酶和蝶酰三嗪还原酶。用活化T淋巴细胞的培养上清液刺激的人巨噬细胞是新蝶呤的主要产生者。在这些细胞中,由于GTP水平高,GTP环化水解酶I活性升高,因此新蝶呤积累。人巨噬细胞缺乏6-丙酮酰四氢蝶呤合酶活性。添加到受刺激的T细胞和巨噬细胞培养基中的外源性四氢生物蝶呤抑制了GTP环化水解酶I活性和新蝶呤浓度的升高,但不抑制细胞内GTP的升高。用重组人干扰素-γ刺激巨噬细胞,并通过添加针对人干扰素-γ的单克隆抗体中和T细胞上清液的作用,结果表明免疫干扰素诱导了GTP环化水解酶I活性和新蝶呤浓度的改变。在人巨噬细胞系U-937和白血病系HL-60中,未检测到GTP环化水解酶I活性或细胞内蝶呤,但GTP水平较高。在小鼠单核细胞中,未检测到新蝶呤,但检测到生物蝶呤和蝶呤。刺激后,生物蝶呤的升高方式与人单核细胞中新蝶呤的升高方式相同。这可以通过人和小鼠中四氢生物蝶呤生物合成限速步骤的不同调节来解释。这些结果表明,新蝶呤是细胞免疫系统激活的非特异性标志物。